Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Most relevant news about SANOFI
04/20Generics group Alvogen puts Eastern European operations up for sale - sources
RE
04/20SANOFI : Advent International enters into exclusive negotiations to acquire Zent..
AQ
04/19UN HEALTH AGENCY : Dengue vaccine shouldn't be used widely
AQ
04/18SANOFI : CFO Jerome Contamine to Depart Later This Year
DJ
04/18SANOFI : in talks with Advent to sell its European generics unit for €1.9bn
AQ
04/17SANOFI : CFO Contamine to retire later this year
RE
04/17SANOFI : Bank trio expected to lead financing on Zentiva sale
RE
04/17SANOFI : to invest EUR350 million in Canadian vaccine facility
AQ
04/17Sanofi in talks to sell generics arm to Advent for 1.9 billion euros
RE
04/17SANOFI : in Talks With Advent International to Sell Zentiva for EUR1.92 Billion
DJ
04/17SWEDISH ORPHAN BIOVITRUM : Sobi publishes 2017 Annual and Sustainability Report
AQ
04/17SANOFI : Advent International enters into exclusive negotiations to acquire Zent..
GL
04/17SANOFI : Advent International enters into exclusive negotiations to acquire Zent..
AQ
04/16SANOFI : France's Sanofi sells 12 brands to Charterhouse's Cooper-Vemedia
RE
04/14SANOFI : Discover the Future of Pharmaceutical Freeze Drying at SMi’s 6th ..
AQ
More most relevant news
All news about SANOFI
04/20Generics group Alvogen puts Eastern European operations up for sale - sources
RE
04/20SANOFI : Advent International enters into exclusive negotiations to acquire Zent..
AQ
04/19UN HEALTH AGENCY : Dengue vaccine shouldn't be used widely
AQ
04/19SANOFI : Advent, near deal to buy Sanofi`s Zentiva, lays out big goals for gener..
AQ
04/19SANOFI : Advent International to acquire Zentiva, Sanofi`s European generics bus..
AQ
04/18SANOFI : in talks with Advent to sell its European generics arm for 1.9bn
AQ
04/18SANOFI : CFO Jerome Contamine to Depart Later This Year
DJ
04/18SANOFI : in talks with Advent to sell its European generics unit for €1.9bn
AQ
04/17SANOFI : CFO Contamine to retire later this year
RE
04/17SANOFI : Advent eyes acquisition of Sanofi’s Zentiva for EUR 1.9bn
AQ
More news
Sector news : Pharmaceuticals - NEC
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From Takeda Pharmaceutical Company L..
DJ
04/20Generics group Alvogen puts Eastern European operations up for sale - sources
RE
04/20P&G's vitamin boost could signal more to come
RE
More sector news : Pharmaceuticals - NEC
Official Publications
03/31Monthly statement on outstanding equity shares and voting rights 
02/07Annual results 
02/07Slide show results 
01/16Share buyback 
2017Monthly statement on outstanding equity shares and voting rights 
2017SEC Filing 20 F 
More official Publications
News from SeekingAlpha
04/20PORTFOLIO STRATEGY REPORT : Why Investors Should Build Shares In Bioscience Stoc.. 
04/20Now See Wall Street's 38 'Safer' International Dividend WallStars For April 
04/18ASLAN Pharmaceuticals Updates U.S. IPO Plans 
04/18Catalyst Pipeline Portfolio Updates - Strong Start To For The Portfolio 
04/17Evelo Biosciences Files For U.S. IPO 
04/17WALL STREET BREAKFAST : Tax Day At The Supreme Court 
Latest Tweets
02:47aThe World Health Organization (WHO) said on Thursday Sanofi’s vaccine against..
3
02:47aThe World Health Organization (WHO) said on Thursday Sanofi’s vaccine against..
2
04/20Sanofi's Dengvaxia should only be used after a confirmation of prior infectio.. 
04/20WHO says Sanofi's Dengvaxia should be used only after a dengue test—but a tes.. 
04/20WHO says now you have to test for dengue exposure before using Sanofi's Dengv.. 
More tweets
Qtime:162
Financials (€)
Sales 2018 35 059 M
EBIT 2018 8 624 M
Net income 2018 4 942 M
Debt 2018 14 584 M
Yield 2018 4,69%
P/E ratio 2018 16,14
P/E ratio 2019 14,28
EV / Sales 2018 2,77x
EV / Sales 2019 2,60x
Capitalization 82 650 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 79,3 €
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & Executive VP-Finance
Elias A. Zerhouni President-Global Research & Development
Ameet Nathwani Executive Vice President-Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-8.70%102 008
JOHNSON & JOHNSON-8.59%342 627
PFIZER0.75%217 064
NOVARTIS-6.21%213 465
ROCHE HOLDING LTD.-12.17%193 713
MERCK AND COMPANY4.21%158 813